Joel Greenblatt's position in Pfizer is currently worth $1.68 Million. That's 0.03% of their equity portfolio (666th largest holding). The first Pfizer trade was made in Q1 2011. Since then Joel Greenblatt bought shares 26 more times and sold shares on 24 occasions. The investor's estimated purchase price is $2.18 Million, resulting in a loss of 23%.